Hippocratic AI, the company that pioneered the first healthcare LLM for patient-facing non-diagnostic clinical tasks, announced that the company completed its series B financing round only nine months after its series A. The series B raised $141 million, valuing the company at $1.64 billion. The funding round was led by Kleiner Perkins. They were joined by existing investors: A16z, General Catalyst, Premji, NVIDIA, SV Angel, Universal Health Services (UHS), and WellSpan Health, which all participated at or above pro-rata.